Condition
Peri-ampullary Tumor
Total Trials
6
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (5)
Trial Status
Completed2
Unknown2
Recruiting1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07321470Not ApplicableRecruitingPrimary
Complete vs. Postoperative Nasogastric Tube Omission in Pancreaticoduodenectomied Patients
NCT04037982Not ApplicableUnknownPrimary
RCT Study on Safety of LPD and OPD in the Treatment of Periampullary Tumors
NCT02281019Completed
SpyGlass AMEA Registry
NCT01569282Not ApplicableWithdrawn
Double Bypass Versus Stent-treatment in Irresectable Pancreatic Cancer
NCT02575014Not ApplicableUnknownPrimary
Pancreaticoduodenectomy With or Without Preoperative Hyperbaric Oxygen Therapy
NCT02372331Not ApplicableCompletedPrimary
The Effect of ERAS on Pancreaticoduodenectomy
Showing all 6 trials